(Q36778016)

English

An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma

scientific article published on 4 March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

0 references

Epstein–Barr virus

0 references

1 reference

based on heuristic

inferred from title

Benjamin Pinsky

object named as

Benjamin A Pinsky

5

0 references

12

object named as

K Kian Ang

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

author name string

Quynh-Thu Le

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Qiang Zhang

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Hongbin Cao

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Ann-Joy Cheng

4

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Ruey-Long Hong

6

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Joseph T Chang

7

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Chun-Wei Wang

8

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Kuo-Chien Tsao

9

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Ym Dennis Lo

10

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Nancy Lee

11

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Anthony T C Chan

13

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

K C Allen Chan

14

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

language of work or name

0 references

publication date

4 March 2013

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Clinical Cancer Research

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

19

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

8

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

2208-2215

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630245

29 September 2017

The role of measurement reliability in clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630245

29 September 2017

Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630245

29 September 2017

Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630245

29 September 2017

Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630245

29 September 2017

Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630245

29 September 2017

Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630245

27 June 2018

Free DNA in the serum of cancer patients and the effect of therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630245

27 July 2018

Long-term survival analysis of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630245

5 September 2018

Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630245

5 September 2018

Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630245

5 September 2018

A comparison study of different PCR assays in measuring circulating plasma epstein-barr virus DNA levels in patients with nasopharyngeal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630245

5 September 2018

Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630245

5 September 2018

Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630245

5 September 2018

Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630245

5 September 2018

Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630245

5 September 2018

Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630245

5 September 2018

p53 mutation in plasma DNA and its prognostic value in breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3630245

20 October 2018

A possible noninvasive method for the detection of bladder cancer in patients: microsatellite analysis of free DNA in urine and blood

1 reference

https://pubmed.ncbi.nlm.nih.gov/23459720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23459720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function

1 reference

https://pubmed.ncbi.nlm.nih.gov/23459720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

https://pubmed.ncbi.nlm.nih.gov/23459720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/23459720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/23459720

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1078-0432.CCR-12-3702

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36778016&oldid=2109523636"